Nvwm, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Nvwm, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$83.14 - $145.99 $599,273 - $1.05 Million	-7,208 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$110.08 - $142.92 $336,514 - $436,906	-3,057 Reduced 29.78%	7,208 $855,000
Q4 2021 Feb 08, 2022	BUY	$99.73 - $148.48 $21,840 - $32,517	219 Added 2.18%	10,265 $1.41 Million
Q3 2021 Nov 03, 2021	SELL	$98.85 - $138.91 $254,538 - $357,693	-2,575 Reduced 20.4%	10,046 $1.39 Million
Q2 2021 Aug 04, 2021	SELL	$65.78 - $105.02 $6,906 - $11,027	-105 Reduced 0.83%	12,621 $1.23 Million
Q1 2021 May 11, 2021	SELL	$64.07 - $91.75 $10,443 - $14,955	-163 Reduced 1.26%	12,726 $870,000
Q4 2020 Feb 09, 2021	BUY	$65.07 - $98.24 $12,818 - $19,353	197 Added 1.55%	12,889 $1.11 Million
Q3 2020 Dec 10, 2020	BUY	$59.04 - $77.95 $8,856 - $11,692	150 Added 1.2%	12,692 $825,000
Q2 2020 Aug 11, 2020	BUY	$29.01 - $74.23 $179,571 - $459,483	6,190 Added 97.45%	12,542 $917,000
Q1 2020 May 08, 2020	BUY	$27.51 - $57.29 $174,743 - $363,906	6,352 New	6,352 $216,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Nvwm, LLC with notifications on news.